Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: a systematic review and meta-analysis.
Dr Laura J O’BYRNE MBBS MSc1,2, Dr Safi G ALQATARI MBBS3, Dr Gillian M MAHER PhD 1,4, Dr Aoife M O’SULLIVAN MB BAO BCh3, Dr Ali S KHASHAN PhD 1,4, Dr Grainne P MURPHY MD*3, Dr Fergus P MCCARTHY PhD *1,2
1 INFANT Research Centre, University College Cork, Cork, Ireland.
2 Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork Ireland
3 Department of Rheumatology, Cork University Hospital, Cork, Ireland
4 School of Public Health, Western Gateway Building, University College Cork, Cork, Ireland.
*Contributed equally.
Conflicts of Interest: The authors report no conflicts of interest.
Source of Funding: This project was funded via an education bursary awarded to Dr Grainne Murphy by UCB pharma. The funder had no role in the design, analysis or interpretation of the research and manuscript and had no part in the research process following funding.
Correspondence: Laura O’Byrne, Department of Obstetrics and Gynaecology, 5th Floor, Cork University Maternity Hospital, Wilton, Cork, Ireland.
E-Mail: lobyrne@ucc.ie